Downregulating BMAL1 or CLOCK triggers reduced cell proliferation rate in the glioblastoma stem cells (GSCs), hepatocellular carcinoma (HCC) cells, and leukemia stem cells, featured by a symbolic cellular response of cell cycle dysregulation (13–15). Here, BMAL1 is linked to leukemia.